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We present a case report of colorectal cancer arising in a young patient with ulcerative colitis of only 6 years
duration. The pathology was unusual with extensive pancolonic involvement in a lintitis plastica fashion. This case
represents a clinical example where colon cancer occurred prior to the onset of recommended screening according
to guidelines regarding patients with ulcerative colitis.
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Colorectal cancer is a serious outcome associated with
ulcerative colitis. However, this risk is correlated with
the duration of inflammation. Current data estimate that
the risk of colorectal cancer in ulcerative colitis is 2% at
10 years, 8% at 20 years, and 18% at 30 years [1]. Signet
ring cell carcinoma is an uncommon form of cancer in
the colon and rectum, representing 1% of cancers in
one series [2]. We present a case of poorly differenti-
ated colonic adenocarcinoma with focal signet ring cell
features involving virtually the entire colon in a linitis
plastica fashion, which may be only the second such
case recorded in the literature [3]. Additionally, our
patient was a 20-year-old female with only a 6-year
history of ulcerative colitis.
Case presentation
The patient presented in May 2013, with dehydration
occurring in the context of a 6-year history of poorly
controlled ulcerative colitis. The patient was very resist-
ant to the recommendation of surgery. Despite trials of
steroids, 5-aminosalicylic acid, and anti-tumor necrosis
factor agents, she continued to have bowel movements
up to ten times per day. She had a several-year history
of amenorrhea. Her weight was 38 kg. She had anasarca,
a serum sodium of 121 mmol/L, a creatinine level of* Correspondence: stan.feinberg@nygh.on.ca
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unless otherwise stated.34 μmol/L, and an albumin level of 10 g/L. Her hemoglobin
was 94 g/L, and her white blood cell count was 7.6 × 109/L.
Imaging revealed pancolitis (Figure 1). On endoscopy, her
colon was markedly foreshortened and straight measuring
45 cm to the ileocecal valve. The entire colon was filled
with pseudopolyps, with no obvious malignancy. Many
biopsies were taken throughout the colon and rectum.
All biopsies were positive for poorly differentiated adeno-
carcinoma with focal signet ring cell differentiation. Her
carcinoembryonic antigen level was within normal range
at 1.1 μg/L. There was no sign of distant metastasis on
radiologic staging. She was optimized preoperatively with
10 days of parenteral nutritional support. Subsequently, the
patient proceeded to surgery. Since biopsies low down
in the rectum had been positive for rectal cancer, there
were no plans to perform a sphincter-sparing procedure.
Traditionally, when operating on a debilitated patient with
colitis, the initial operation is a subtotal colectomy. In this
patient, due to the pancolonic nature of the cancer, the
decision was made to perform a total proctocolectomy to
avoid transecting malignancy. Initially, the surgeon began
with a laparoscopic approach but conversion to an open
procedure occurred early, as the bowel was markedly
thickened and boggy, causing concern that there could be
potential spillage. The patient’s postoperative course was
unremarkable.
Pathologic findings confirmed that there was con-
tinuous involvement of the mucosa of the entire colon
with flattening and multiple pseudopolyps (Figure 2). No
discrete tumor was identified. On microscopic examination,al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Computed tomography scan demonstrating diffuse
colonic thickening.
Figure 3 Microscopic image of poorly differentiated
adenocarcinoma invading into submucosa.
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with focal signet ring cell features from the cecum to the
dentate line. This also extended into the ileocecal valve and
distal terminal ileum. This diffuse infiltration pattern is
known as linitis plastica. The resection margins were all
negative. It was very unusual that virtually the entire muco-
sal surface was involved with cancer. There was invasion
into the submucosa, classifying the lesion as pT1 (Figure 3).
Small intervening areas of uninvolved mucosa showed
histological features of chronic colitis with foci of flat and
polypoid high-grade dysplasia. Eighty-two lymph nodes
were retrieved with the specimen and sixty-five of them
contained metastatic adenocarcinoma. The pathologic
findings were confirmed separately at the University
Health Network in Toronto, Canada.Figure 2 Gross appearance of the colon.The patient completed twelve cycles of adjuvant FOL-
FOX over 6 months. She is currently disease free.Conclusion
Colonic linitis plastica is extremely rare, estimated at less
than 0.1% of colon cancers [4]. Secondary linitis plastica
of the colon is more common and the treating team
should consider investigating for a primary tumor.
It is difficult to determine when to initiate screening
colonoscopy for colorectal cancer detection in patients
with ulcerative colitis. Prior reports of low incidence of
malignancy among patients without longstanding colitis
[1] lend to establishing guidelines that use duration of
disease as a criterion. This is problematic since there is a
distinction between the initiation of symptoms and the
official diagnosis. Nonetheless, major American and
international associations have published guidelines that
recommend screening for dysplasia should begin after
8 years of disease activity in ulcerative colitis [5-7].
There are specific stipulations for patients with pancoli-
tis or primary sclerosing cholangitis, but none of the
guidelines recommend initiating screening prior to the
8-year mark. This case challenges those guidelines, as
the patient presented with extensive colonic neoplasia
after just 6 years of disease activity.
Despite a low overall risk of colorectal cancer in pa-
tients with ulcerative colitis of relatively short duration,
there is evidence that malignancies may be missed in
that initial window. A retrospective Dutch nationwide
population-based analysis found that approximately 20%
of colorectal cancer cases in patients with ulcerative col-
itis presented prior to the recommended initiation of
screening colonoscopy [8]. Thus, it may not be adequate
to use duration of disease as an isolated clinical marker
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of disease [9] and presence of pseudopolyps [10] contrib-
ute to increase the risk of developing colorectal cancer.
It is also possible that the immunosuppressive effect of
long term anti-tumor necrosis factor therapy may have
been a predisposing factor. We propose initiating screen-
ing for colorectal cancer in ulcerative colitis earlier in
patients that have these worrisome features. In those with-
out reasonable symptom control, colonoscopy should be
performed regularly. Furthermore, altering the medical
treatment or surgical intervention should be considered.
In our patient, optimal care would have entailed subtotal
colectomy prior to diagnosing malignancy simply on the
basis of refractory disease with severe malnutrition.Consent
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